Home › Compare › EPYFF vs JNJ

EPYFF vs JNJ: Dividend Comparison 2026

EPYFF yields 105263.16% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 EPYFF wins by $8.064713171987811e+26M in total portfolio value
10 years
EPYFF
EPYFF
● Live price
105263.16%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$8.064713171987811e+26M
Annual income
$804,966,999,868,734,400,000,000,000,000,000.00
Full EPYFF calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — EPYFF vs JNJ

📍 EPYFF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodEPYFFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, EPYFF + JNJ cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
EPYFF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

EPYFF
Annual income on $10K today (after 15% tax)
$8,947,368.42/yr
After 10yr DRIP, annual income (after tax)
$684,221,949,888,424,200,000,000,000,000,000.00/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, EPYFF beats the other by $684,221,949,888,424,200,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of EPYFF + JNJ for your $10,000?

EPYFF: 50%JNJ: 50%
100% JNJ50/50100% EPYFF
Portfolio after 10yr
$4.0323565859939053e+26M
Annual income
$402,483,499,934,367,200,000,000,000,000,000.00/yr
Blended yield
99.81%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

EPYFF
No analyst data
Altman Z
-1039.0
Piotroski
3/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

EPYFF buys
0
JNJ buys
0
No recent congressional trades found for EPYFF or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricEPYFFJNJ
Forward yield105263.16% ✓3.36%
Annual dividend / share$2.00$4.96 ✓
Payout ratio50% ✓55%
1-year div growth0%4.2% ✓
5-year div CAGR0%5.8% ✓
Portfolio after 10y$8.064713171987811e+26M$20.0K ✓
Annual income after 10y$804,966,999,868,734,400,000,000,000,000,000.00 ✓$827.78
Total dividends collected$8.063727433132777e+26M ✓$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: EPYFF vs JNJ ($10,000, DRIP)

YearEPYFF PortfolioEPYFF Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$10,537,016$10,526,315.79$10,676$355.77+$10.53M → EPYFF
2$10,377,251,773$10,365,977,166.23$11,407$389.39+$10377.24M → EPYFF
3$9,552,044,282,229$9,540,940,622,831.33$12,198$426.53+$9552044.27M → EPYFF
4$8,217,919,074,277,338$8,207,698,386,895,354.00$13,056$467.62+$8217919074.26M → EPYFF
5$6,608,173,294,209,699,000$6,599,380,120,800,222,000.00$13,987$513.12+$6608173294209.68M → EPYFF
6$4,966,582,566,903,309,000,000$4,959,511,821,478,505,000,000.00$14,998$563.56+$4966582566903309.00M → EPYFF
7$3,488,939,161,660,980,000,000,000$3,483,624,918,314,393,500,000,000.00$16,098$619.52+$3488939161660979712.00M → EPYFF
8$2,290,823,651,613,942,000,000,000,000$2,287,090,486,710,964,800,000,000,000.00$17,295$681.69+$2.2908236516139422e+21M → EPYFF
9$1,405,904,046,772,744,300,000,000,000,000$1,403,452,865,465,517,400,000,000,000,000.00$18,599$750.82+$1.4059040467727442e+24M → EPYFF
10$806,471,317,198,781,100,000,000,000,000,000$804,966,999,868,734,400,000,000,000,000,000.00$20,022$827.78+$8.064713171987811e+26M → EPYFF

EPYFF vs JNJ: Complete Analysis 2026

EPYFF — Stock

ePlay Digital Inc., through its subsidiary, Mobovivo Inc., provides a social game engine and content marketing platform to engage audiences in Canada. Its solutions integrate TV, video, sports, daily fantasy, and social games into multiplatform destinations and campaigns for brands, sports teams, and venues. The company also operates Klocked World, an augmented reality virtual sports app; Klocked Fitness app and Klocked Sportsnet app; Big Shot Basketball app; and Fan Freak, a sports gaming app. ePlay Digital Inc. is headquartered in Calgary, Canada.

Full EPYFF Calculator →

JNJ — Healthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this EPYFF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

EPYFF vs SCHDEPYFF vs JEPIEPYFF vs OEPYFF vs KOEPYFF vs MAINEPYFF vs ABBVEPYFF vs MRKEPYFF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.